Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP653237.RAX5e1TQHhgNNYNDisBnQo9Zmf7MsbolQ1qsf3bY8sX2M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP653237.RAX5e1TQHhgNNYNDisBnQo9Zmf7MsbolQ1qsf3bY8sX2M130_assertion type Assertion NP653237.RAX5e1TQHhgNNYNDisBnQo9Zmf7MsbolQ1qsf3bY8sX2M130_head.
- NP653237.RAX5e1TQHhgNNYNDisBnQo9Zmf7MsbolQ1qsf3bY8sX2M130_assertion description "[Suggestive but notable results were (a) gene-based tests suggesting roles for adenylate cyclase 3 (ADCY3, 2p23.3) and galanin (GAL, 11q13.3); published functional evidence relates both of these to MDD and serotonergic signaling; (b) support for the bipolar disorder risk variant SNP rs1006737 in CACNA1C (P=0.020, odds ratio=1.10); and (c) lack of support for rs2251219, a SNP identified in a meta-analysis of affective disorder studies (P=0.51).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653237.RAX5e1TQHhgNNYNDisBnQo9Zmf7MsbolQ1qsf3bY8sX2M130_provenance.
- NP653237.RAX5e1TQHhgNNYNDisBnQo9Zmf7MsbolQ1qsf3bY8sX2M130_assertion evidence source_evidence_literature NP653237.RAX5e1TQHhgNNYNDisBnQo9Zmf7MsbolQ1qsf3bY8sX2M130_provenance.
- NP653237.RAX5e1TQHhgNNYNDisBnQo9Zmf7MsbolQ1qsf3bY8sX2M130_assertion SIO_000772 21042317 NP653237.RAX5e1TQHhgNNYNDisBnQo9Zmf7MsbolQ1qsf3bY8sX2M130_provenance.
- NP653237.RAX5e1TQHhgNNYNDisBnQo9Zmf7MsbolQ1qsf3bY8sX2M130_assertion wasDerivedFrom befree-20140225 NP653237.RAX5e1TQHhgNNYNDisBnQo9Zmf7MsbolQ1qsf3bY8sX2M130_provenance.
- NP653237.RAX5e1TQHhgNNYNDisBnQo9Zmf7MsbolQ1qsf3bY8sX2M130_assertion wasGeneratedBy ECO_0000203 NP653237.RAX5e1TQHhgNNYNDisBnQo9Zmf7MsbolQ1qsf3bY8sX2M130_provenance.